SCHEMBL7255659

SCHEMBL7255659

O=C(O)c1ccc(CNc2nc(N3CCCCC3)nc3ccccc23)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTNNB1 P35222 12/20 0.72
TCF7L2 Q9NQB0 12/20 0.72
PDE5A O76074 2/20 0.61
HRH4 Q9H3N8 1/20 0.61
HTR2A P28223 1/20 0.60
DRD3 P35462 1/20 0.60
KDM4E B2RXH2 3/20 0.59
MAPT P10636 1/20 0.59
MAPK1 P28482 1/20 0.59
NPSR1 Q6W5P4 1/20 0.59
GLA P06280 2/20 0.59
TSHR P16473 2/20 0.59
HSD17B10 Q99714 2/20 0.59
ALDH1A1 P00352 1/20 0.59
LMNA P02545 1/20 0.59
GAA P10253 1/20 0.59
THRB P10828 1/20 0.59
HPGD P15428 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
MEN1 O00255 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3642575 0.89 CTNNB1 (0.68) CTNNB1TCF7L2PDE5AHRH4HTR2A
SCHEMBL2592377 0.88 PDE5A (0.77) CTNNB1TCF7L2PDE5AHRH4HTR2A
SCHEMBL3639211 0.88 PDE5A (0.77) CTNNB1TCF7L2PDE5AHRH4HTR2A
SCHEMBL3644763 0.87 PDE5A (0.65) CTNNB1TCF7L2PDE5AHRH4HTR2A
SCHEMBL3643346 0.87 PDE5A (0.79) CTNNB1TCF7L2PDE5AHRH4HTR2A
SCHEMBL7258161 0.86 CTNNB1 (0.57) CTNNB1TCF7L2PDE4APDE4BPDE4C
SCHEMBL3641690 0.85 CTNNB1 (0.76) CTNNB1TCF7L2PDE5AHRH4HTR2A
SCHEMBL3640595 0.85 PDE5A (0.69) CTNNB1TCF7L2PDE5AHRH4HTR2A
SCHEMBL3644267 0.85 KDM4E (0.66) CTNNB1TCF7L2PDE5AHRH4HTR2A
SCHEMBL4179551 0.84 CTNNB1 (1.00) CTNNB1TCF7L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003055866-A1 QUINAZOLINE AND QUINOLINE DERIVATIVE COMPOUNDS AS INHIBITORS OF PROLYLPEPTIDASE, INDUCERS OF APOPTOSIS AND CANCER TREATMENT AGENTS BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-10 WO disclosed